Faes Farma, a Spanish pharmaceutical company headquartered near Bilbao, is using a Syrris Asia Flow Chemistry System to develop novel synthesis pathways for new and existing active pharmaceutical ingredients (APIs).   “We are interested in using flow chemistry to allow us to perform reactions that would be too dangerous in a batch set-up, because they are either very exothermic or involve highly corrosive media,” said Pablo Morán, a chemical innovation scientist in Faes Farma’s R&D departmen...